InsiderClue
Stocks · Health care · Services-Medical Laboratories

Caris Life Sciences, Inc.

CAI Clue Score63
United States Fiscal year ends December CIK 0002019410 Results filed 4 Nov 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

12
Insider
Date
Role
Action
Shares
Price
Amount
John Russel Denton
22 Sep 2026
See Remarks
Sell
7,500
$31.82
$238.63K
Brian J Brille
17 Sep 2026
See Remarks
Sold after exercise
400,000
$30.33
$12.13M
David Baxley Spetzler
4 Sep 2026
President
Sold after exercise
119,212
$24.76
$2.95M
David Baxley Spetzler
3 Sep 2026
President
Sold after exercise
84,900
$25.32
$2.15M
David Baxley Spetzler
3 Sep 2026
President
Sold after exercise
393,100
$24.76
$9.73M
Jon Halbert
15 May 2026
Director
Buy indirect
68,000
$14.56
$990.08K
Jeff L Vacirca
11 May 2026
Director
Buy
31,050
$16.15
$501.43K
Peter M Castleman
9 Jan 2026
Director
Exercised, kept
2,500
$18.60
$46.50K
Luke Thomas Power
11 Dec 2025
See Remarks
Sold after exercise
1,400
$27.16
$38.02K
Luke Thomas Power
11 Dec 2025
See Remarks
Sold after exercise
60,850
$26.56
$1.62M
David Baxley Spetzler
7 Nov 2025
President
Buy
400
$23.85
$9.54K
John Russel Denton
7 Nov 2025
See Remarks
Buy indirect
4,184
$24.09
$100.79K

What was left out

Form 4 filings counted 36
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 6
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 2,542,753
History held since 23 Jun 2025